查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1743895

全球猪隻疫苗市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Swine Vaccines Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格

全球猪隻疫苗市场规模预计将从 2024 年的 21.6 亿美元成长到 2033 年的 34.9 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 5.49%。

受猪群传染病日益普及的推动，猪隻疫苗市场可望强劲成长。随着全球猪肉需求持续成长，制定有效的疫苗接种策略以确保猪群健康和生产力变得至关重要。新型病原体的出现以及先前已控制的疾病的復发，使得疫苗製剂的持续研发成为必要。各公司正在大力投资创新技术，例如重组疫苗和基于mRNA的解决方案，这些技术有望提高疫苗的有效性和安全性，从而应对养猪生产者面临的日益严峻的挑战。

此外，畜牧养殖户对生物安全措施的意识不断增强，这对猪隻疫苗市场产生了重大影响。生产者越来越认识到疫苗接种作为全面猪群管理策略关键组成部分的重要性。这种观念的转变正在促进积极主动的疾病预防，从而提高疫苗接种率，并最终增强猪群的抵抗。用于监测和管理疫苗接种计划的数位工具整合也越来越受到关注，使养殖户能够优化猪群健康管理实践并提高整体生产力。

此外，全球养猪业的扩张，尤其是在新兴市场的扩张，为猪隻疫苗市场带来了丰厚的利润。随着各国努力提高畜牧业生产能力以满足日益增长的消费需求，采用先进的疫苗接种计画变得至关重要。疫苗製造商与农业组织之间的合作有望促进知识转移，并改善这些地区获得疫苗接种技术的途径。猪疫苗市场的未来前景光明，其特点是持续创新、疾病管理意识的提高以及对改善动物健康和福利的承诺。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了竞争态势以及领先公司采用的关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新以及潜在投资领域。本部分将深入探讨未来市场发展与成长前景。

目录

第一章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：猪疫苗产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品进行市场吸引力分析
    • 依疾病类型分析市场吸引力
    • 按最终用户进行的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第五章：全球猪疫苗市场分析：依产品

  • 产品概览
  • 按产品进行的历史和预测数据分析
  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗
  • 亚单位疫苗
  • 类毒素疫苗
  • 其他产品

第六章：全球猪疫苗市场分析：依疾病类型

  • 依疾病类型概述
  • 按疾病类型进行的历史和预测数据分析
  • 猪繁殖与呼吸综合症（PRRS）
  • 猪圆环病毒2型（PCV2）
  • 猪肺炎支原体
  • 猪瘟（CSF）
  • 猪流感
  • 丹毒
  • 口蹄疫（FMD）
  • 非洲猪瘟（ASF）
  • 猪细小病毒
  • 其他疾病类型

第七章：全球猪疫苗市场分析：按最终用户

  • 最终用户概览
  • 最终用户的历史和预测数据分析
  • 兽医医院和诊所
  • 养猪场
  • 研究机构

第八章：全球猪疫苗市场分析：按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章：猪疫苗公司的竞争格局

  • 猪疫苗市场竞争
  • 伙伴关係/合作/协议
  • 併购
  • 新产品发布
  • 其他发展

第十章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Biogenesis Bago
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bioveta
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim International GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ceva SantA(C) Animale
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elanco Animal Health Incorporated
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • HIPRA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Indian Immunologicals Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Phibro Animal Health Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Vaxxinova
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Virbac
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Zoetis Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11214069

Global Swine Vaccines Market size is anticipated to grow from USD 2.16 Billion in 2024 to USD 3.49 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.49% during the forecast period of 2026 to 2033.

The swine vaccines market is set for robust growth, driven by the increasing prevalence of infectious diseases affecting pig populations. As the global demand for pork continues to rise, the need for effective vaccination strategies to ensure herd health and productivity becomes paramount. The emergence of novel pathogens and the resurgence of previously controlled diseases necessitate ongoing research and development in vaccine formulations. Companies are investing heavily in innovative technologies, such as recombinant vaccines and mRNA-based solutions, which promise enhanced efficacy and safety profiles, thereby addressing the evolving challenges faced by swine producers.

Moreover, the growing awareness of biosecurity measures among livestock farmers is significantly influencing the swine vaccines market. Producers are increasingly recognizing the importance of vaccination as a critical component of comprehensive herd management strategies. This shift in mindset is fostering a proactive approach to disease prevention, leading to higher vaccination rates and, consequently, a more resilient swine population. The integration of digital tools for monitoring and managing vaccination schedules is also gaining traction, enabling farmers to optimize their herd health management practices and improve overall productivity.

Additionally, the expansion of the global swine industry, particularly in emerging markets, presents lucrative opportunities for the swine vaccines market. As countries strive to enhance their livestock production capabilities to meet growing consumer demand, the adoption of advanced vaccination programs becomes essential. Collaborations between vaccine manufacturers and agricultural organizations are expected to facilitate knowledge transfer and improve access to vaccination technologies in these regions. The future of the swine vaccines market appears promising, characterized by continuous innovation, increased awareness of disease management, and a commitment to enhancing animal health and welfare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Inactivated vaccines
  • Live attenuated vaccines
  • Recombinant vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • Other products

By Disease Type

  • Porcine reproductive and respiratory syndrome (PRRS)
  • Porcine circovirus type 2 (PCV2)
  • Mycoplasma hyopneumoniae
  • Classical swine fever (CSF)
  • Swine influenza
  • Erysipelas
  • Foot-and-Mouth disease (FMD)
  • African swine fever (ASF)
  • Porcine parvovirus
  • Other disease types

By End-user

  • Veterinary hospitals & clinics
  • Swine farms
  • Research institutes
  • COMPANIES PROFILED
  • Biogenesis Bago
  • Bioveta
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova
  • Virbac
  • Zoetis Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SWINE VACCINES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Inactivated vaccines Historic and Forecast Sales By Regions
  • 5.4. Live attenuated vaccines Historic and Forecast Sales By Regions
  • 5.5. Recombinant vaccines Historic and Forecast Sales By Regions
  • 5.6. Subunit vaccines Historic and Forecast Sales By Regions
  • 5.7. Toxoid vaccines Historic and Forecast Sales By Regions
  • 5.8. Other products Historic and Forecast Sales By Regions

6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY DISEASE TYPE

  • 6.1. Overview By Disease Type
  • 6.2. Historical and Forecast Data Analysis By Disease Type
  • 6.3. Porcine reproductive and respiratory syndrome (PRRS) Historic and Forecast Sales By Regions
  • 6.4. Porcine circovirus type 2 (PCV2) Historic and Forecast Sales By Regions
  • 6.5. Mycoplasma hyopneumoniae Historic and Forecast Sales By Regions
  • 6.6. Classical swine fever (CSF) Historic and Forecast Sales By Regions
  • 6.7. Swine influenza Historic and Forecast Sales By Regions
  • 6.8. Erysipelas Historic and Forecast Sales By Regions
  • 6.9. Foot-and-Mouth disease (FMD) Historic and Forecast Sales By Regions
  • 6.10. African swine fever (ASF) Historic and Forecast Sales By Regions
  • 6.11. Porcine parvovirus Historic and Forecast Sales By Regions
  • 6.12. Other disease types Historic and Forecast Sales By Regions

7. GLOBAL SWINE VACCINES MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Veterinary hospitals & clinics Historic and Forecast Sales By Regions
  • 7.4. Swine farms Historic and Forecast Sales By Regions
  • 7.5. Research institutes Historic and Forecast Sales By Regions

8. GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES

  • 9.1. Swine Vaccines Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF SWINE VACCINES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Biogenesis Bago
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Bioveta
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Boehringer Ingelheim International GmbH
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Ceva SantA(C) Animale
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Elanco Animal Health Incorporated
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. HIPRA
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Indian Immunologicals Limited
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Merck & Co. Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Phibro Animal Health Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Vaxxinova
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Virbac
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Zoetis Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Inactivated vaccines Market Sales By Geography (USD MN)
  • Live attenuated vaccines Market Sales By Geography (USD MN)
  • Recombinant vaccines Market Sales By Geography (USD MN)
  • Subunit vaccines Market Sales By Geography (USD MN)
  • Toxoid vaccines Market Sales By Geography (USD MN)
  • Other products Market Sales By Geography (USD MN)
  • Analysis By Disease Type (USD MN)
  • Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
  • Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
  • Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
  • Classical swine fever (CSF) Market Sales By Geography (USD MN)
  • Swine influenza Market Sales By Geography (USD MN)
  • Erysipelas Market Sales By Geography (USD MN)
  • Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
  • African swine fever (ASF) Market Sales By Geography (USD MN)
  • Porcine parvovirus Market Sales By Geography (USD MN)
  • Other disease types Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Veterinary hospitals & clinics Market Sales By Geography (USD MN)
  • Swine farms Market Sales By Geography (USD MN)
  • Research institutes Market Sales By Geography (USD MN)
  • Global Swine Vaccines Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Swine Vaccines Report
  • Market Research Process
  • Market Research Methodology
  • Global Swine Vaccines Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Inactivated vaccines Market Sales By Geography (USD MN)
  • Live attenuated vaccines Market Sales By Geography (USD MN)
  • Recombinant vaccines Market Sales By Geography (USD MN)
  • Subunit vaccines Market Sales By Geography (USD MN)
  • Toxoid vaccines Market Sales By Geography (USD MN)
  • Other products Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Type (USD MN)
  • Porcine reproductive and respiratory syndrome (PRRS) Market Sales By Geography (USD MN)
  • Porcine circovirus type 2 (PCV2) Market Sales By Geography (USD MN)
  • Mycoplasma hyopneumoniae Market Sales By Geography (USD MN)
  • Classical swine fever (CSF) Market Sales By Geography (USD MN)
  • Swine influenza Market Sales By Geography (USD MN)
  • Erysipelas Market Sales By Geography (USD MN)
  • Foot-and-Mouth disease (FMD) Market Sales By Geography (USD MN)
  • African swine fever (ASF) Market Sales By Geography (USD MN)
  • Porcine parvovirus Market Sales By Geography (USD MN)
  • Other disease types Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Veterinary hospitals & clinics Market Sales By Geography (USD MN)
  • Swine farms Market Sales By Geography (USD MN)
  • Research institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.